Novavax (NASDAQ:NVAX) major shareholder Pharmaceuticals Ltd Cadila sold 3,000,000 shares of the stock on the open market in a transaction dated Friday, March 21st. The shares were sold at an average price of $4.95, for a total transaction of $14,850,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC. Novavax, Inc. (NASDAQ:NVAX) shares after opening at $4.68 moved to $4.72 on last trade day and at the end of the day closed at $4.13. Company price to sales ratio in past twelve months was calculated as 41.68 and price to cash ratio as 4.75. Novavax, Inc. (NASDAQ:NVAX) showed a positive weekly performance of -21.48%.
Trina Solar Limited (ADR) (NYSE:TSL) released a favorable settlement assisted it revise its Q4 earnings higher. The Chinese solar panel maker declared that it has profit for the period had already exceeded Wall Street anticipations at what time they were reported earlier this month. Trina Solar Limited (ADR) (NYSE:TSL) shares fell -8.85% in last trading session and ended the day on $14.22. TSL return on equity ratio is recorded as -20.30% and its return on assets is -6.30%. Trina Solar Limited (ADR) (NYSE:TSL) yearly performance is 266.49%.
Investors certainly have to be happy with Peregrine Pharmaceuticals (NASDAQ:PPHM) and its short term performance. After all, the stock has jumped by 32.6% in the past 4 weeks, and it is also above its 20 Day Simple Moving Average as well. Peregrine Pharmaceuticals (NASDAQ:PPHM) shares moved down -9.38% in last trading session and was closed at $2.03, while trading in range of $1.93 – 2.27. Peregrine Pharmaceuticals (NASDAQ:PPHM) year to date (YTD) performance is 46.04%.
Allied Nevada Gold (AMEX:ANV)‘s stock had its “market perform” rating reaffirmed by investment analysts at Cowen and Company in a note issued to investors on Friday, American Banking News reports. Allied Nevada Gold Corp.(NYSEMKT:ANV) weekly performance is -16.23%. On last trading day company shares ended up $5.11. Allied Nevada Gold Corp.(NYSEMKT:ANV) distance from 50-day simple moving average (SMA50) is -0.97%. Analysts mean target price for the company is $5.63.